If pharmaceutical tariffs are implemented what are some good US API manufacturing stocks to buy

Trump administration is currently evaluating pharmaceutical tariffs and seems like they’ll be issued within next 1-2 months. If they are I suspect some US based API (active pharmaceutical ingredients) manufacturing companies may have increased demand and could see a bump up in their stock price. I’m trying to proactively research to find potential candidates (either pharma companies making their own API or companies just dedicated to APIs).

From what I’m seeing a lot of the pharma companies like Pfizer, Merck, teva have domestic manufacturing locations but also global (as well as both importing and exporting meds). So I’m not sure how their bottom lines will be impacted without a deep dive on each.

Perrigo is an OTC API provider that has US based manufacturing locations (maybe global too, not sure from some researching). Looking for companies that similarly have all or a substantial % of their manufacturing within the US and could boon if tariffs on importing drive more production within the US.